Giant Biogene Holding First Financial Report Since Going Public: Strong Performance from Core Brands, Increasing Revenue Share

3月 30, 2023

On the evening of March 27, Giant Biogene Holding (HK:02367), a professional skincare company, released its first financial report since going public. In the 2022 fiscal year, the company’s sales revenue increased by 52.3% year-on-year to RMB 2.3644 billion, and net profit attributable to shareholders increased by 21% year-on-year to RMB 1.002 billion.
After the financial report was released, Giant Biogene’s stock price fell by 8.89% to HKD 47.65 on March 28th. Since its IPO, the company’s stock price has accumulated an 83.27% increase, and its current market value i …

Brand: Giant Biogene
Tags: China brand Public Chinese company

Giant Biogene Holding First Financial Report Since Going Public: Strong Performance from Core Brands, Increasing Revenue Share

Pop Mart Hits HKD 100 Billion Market Cap! Q3 Revenue Surges 120%, Stock Soars 20%

JNBY Reports ¥5.24 Billion Revenue, Growth Brands Exceed 40%

Anta Group’s Revenue Grew by 13.8% in the First Half of the Year, Setting a Record for Its Best Mid-Year Performance

China Watch Financial Summary

Giant Biogene Holding First Financial Report Since Going Public: Strong Performance from Core Brands, Increasing Revenue Share

Read More

Pop Mart Hits HKD 100 Billion Market Cap! Q3 Revenue Surges 120%, Stock Soars 20%

JNBY Reports ¥5.24 Billion Revenue, Growth Brands Exceed 40%

Anta Group’s Revenue Grew by 13.8% in the First Half of the Year, Setting a Record for Its Best Mid-Year Performance